Environmental Health and Preventive Medicine
Online ISSN : 1347-4715
Print ISSN : 1342-078X
ISSN-L : 1342-078X
The association of family history of herpes zoster and the risk of incident herpes zoster: the SHEZ Study
Keiko KinumakiHironori ImanoYukiko TakaoYoshinobu OkunoYasuko MoriHideo AsadaKoichi YamanishiHiroyasu Iso
著者情報
ジャーナル オープンアクセス HTML

2022 年 27 巻 p. 22

詳細
Abstract

Background: We investigated whether family histories of herpes zoster (HZ) are associated with the risk of incident HZ in a Japanese population.

Methods: A total of 12,522 Japanese residents aged ≥50 years in Shozu County participated in the baseline survey between December 2008 and November 2009 (the participation rate = 72.3%). They were interviewed at baseline by research physicians regarding the registrants’ history of HZ. A self-administered questionnaire survey was conducted to evaluate the potential confounding factors. 10,530 participants without a history of HZ were followed up to ascertain the incidence of HZ during 3-years follow-up until the end of November 2012 with Japanese nationals. We estimated hazard ratios (HRs) of incident HZ according to first-degree family histories using the Cox proportional hazard regression after adjusting for age, sex, and other potential confounding factors.

Results: Compared to no HZ history of each family member, a history of brother or sister was associated with a higher risk of incident HZ while histories of father and mother were not. The multivariable HR (95%CI) of incident HZ for a history of brother or sister was 1.67 (1.04–2.69). When comparing to no family histories of all first-degree relatives, the multivariable HRs (95%CIs) were 1.34 (0.77–2.34) for a history of brother or sister alone, but 4.81 (1.78–13.00) for a history of mother plus brother or sister. As for the number of family histories, the multivariable HRs (95%CIs) were 1.08 (0.76–1.54) for one relative (father, mother, or brother or sister) and 2.75 (1.13–6.70) for two or more relatives.

Conclusion: Family histories of mother plus brother or sister and two or more first-degree relatives were associated with a higher risk of incident HZ.

Background

Herpes zoster (HZ) is a painful disease caused by varicella-zoster virus (VZV) infection. Patients with HZ usually experience painful vesicular rashes with erythema, which generally take 3–4 weeks to heal [1]. According to a 2017 investigation by the Ministry of Health, Labour and Welfare, the number of patients with HZ was approximately 13,900 per year in Japan [2]. VZV causes varicella in childhood as an initial stage of infection; the VZV then latently infects the sensory nerve ganglia of the host, where the virus is reactivated, usually by reduction of immune function [3].

A family history of HZ has been reported as a risk factor for HZ [410] for which the Interleukin (IL)-10 promotor polymorphism among Koreans [11] and apolipoprotein E-ε4 polymorphism among Caucasian women [12] were associated with susceptibility of HZ. However, previous studies came from retrospective case-control studies in the United States, Europe, Iran, and China. No prospective study has investigated the association between a family history of HZ and the risk of incident HZ. Retrospective case-control studies are susceptible to selection, recall, interviewer biases and failure of control for potential confounding variables which could distort the association.

Potential confounding variables other than age and sex were lower body mass index (BMI) [13], smoking [14], drinking [15], mental stress [16], motivation [16], negative life event [16], underlying diseases such as hypertension, hyperlipidemia, diabetes mellitus [17], cancer [18], and connective tissue diseases [19].

The goal of the present study was to examine whether first-degree family histories of HZ and the number of these family histories were positively associated with the risk of incident HZ in a free-living general population.

Methods

Study subjects

A prospective cohort study was undertaken in Shozu County, Kagawa Prefecture, consisting mainly of Shodoshima and Toyoshima Islands with a census population of 33,782, of which 32.8% were 65 years or older on July 1, 2008. The detailed methods of this study have been described elsewhere [20].

The eligible study subjects were 19,058 (8,424 men and 10,634 women) Japanese residents aged ≥50 years on October 1, 2008. The provisional registration was performed for 12,896 persons by confidential mail, and those who completed the informed consent were formally registered. Eventually, 12,522 (5,587 men and 6,935 women) were registered between December 2008 and November 2009 (the overall participation rate among total residents = 72.3%).

We excluded 1,992 (667 men and 1,325 women) participants who had a past history of HZ, the remaining 10,530 (4,920 men and 5,610 women) were included in the analysis. The participants’ enrollment process is shown in Figure 1.

Fig. 1

Flow chart of the selection for study participants

Data collection and follow-up

At baseline survey, an interview was conducted by research physicians to inquire about the participants’ history of HZ and when it had occurred, and whether they had visited a clinic or hospital. A self-administered questionnaire was used to evaluate factors including age, height, weight, and current health status (smoking status, drinking status, mental stress, motivation, life events, and underlying diseases such as hypertension, hyperlipidemia, diabetes mellitus, connective tissue disease, leukemia, and cancer), and family histories of first-degree relatives (father, mother, brother or sister) of HZ.

Telephone surveys were conducted every four weeks to confirm the presence or absence of rash, pain, history of contact with patients with varicella, and admission to a clinic or hospital. Participants with symptoms suspicious for HZ, including rash had been asked to visit a clinic or hospital, and underwent blood tests. We directed most of all participants to consult a physician soon after developing symptoms in the monthly telephone assessments.

The duration of the follow-up was between April 2009 and November 2012.

Statistical analysis

Differences in baseline characteristics according to the presence or absence of family histories of HZ were examined using the analysis of variance for mean values and chi-square test for frequency. The crude, age- and sex-adjusted, and multivariable HRs and 95% CIs of incident HZ were calculated according to the family histories using a Cox proportional hazard regression model, adjusting for age, sex, and other confounding variables.

The family histories of HZ were categorized into the presence versus absence of each family member, i.e., father, mother, and brother or sister, and the presence of father only, mother only, brother or sister only, father and mother, father and brother or sister, mother and brother or sister, and all of them versus the absence of all relatives. The number of family histories of HZ was grouped into none, one, and two or more of histories for father, mother and brother or sister.

The confounding factors for the multiple adjustment were BMI (kg/m2) calculated as the body weight divided by the square of the height, smoking status (never, former, and current smoker of 1–9, 10–19 and ≥20 cigarettes per day), drinking status (never, former, and current drinkers of <23, 23–45 and ≥46 g of ethanol per day), perceived mental stress (very high to high, moderate, and low), motivation (very high to high, moderate, and low), negative life events (no or yes), and underlying diseases (hypertension, hyperlipidemia, diabetes mellitus, cancer, and connective tissue diseases). All statistical analyses were performed using SAS for Windows (version 9.4; SAS Inc., Cary, NC, USA). P-values for statistical tests were two-tailed, and values <0.05 were considered statistically significant.

Results

Table 1 shows the baseline characteristics according to family histories of HZ. Father’s history was positively associated with younger ages, mental stress, life events, and fewer underlying diseases. Mother’s history was positively associated with female sex, younger ages, BMI, mental stress, motivation, and fewer underlying diseases. A history of brother or sister was positively associated with female sex, non-smoking, non-drinking and more underlying diseases. The number of family history of HZ was positively associated with younger ages, non-drinking, and fewer underlying diseases.

Table 1 Baseline characteristics according to family histories of herpes zoster.
  Total participants Father’s history
of HZ
P for differences Mother’s history
of HZ
P for differences Brother’s or sister’s history of HZ P for differences Any relatives P for differences
No Yes No Yes No Yes 0 1 ≥2
Number 10530 10310 220   9885 645   10204 326   9407 1058 65  
Women, % 53.3 53.2 56.8 0.287 53.0 57.4 0.032 52.8 68.1 <0.001 52.4 60.4 58.5 <0.001
Age, year 67.8 (10.6) 68.0 (10.6) 59.3 (6.8) <0.001 68.2 (10.6) 61.2 (7.6) <0.001 67.8 (10.7) 66.8 (9.1) 0.082 68.4 (10.7) 62.6 (8.5) 60.4 (7.4) <0.001
Body mass index, kg/m2 22.8 (3.3) 22.8 (3.3) 22.7 (3.0) 0.601 22.8 (3.3) 23.1 (3.2) 0.028 22.8 (3.3) 23.1 (3.5) 0.104 22.8 (3.4) 23.0 (3.2) 22.9 (3.5) 0.061
Smoking status
 Non-smoker, % 57.7 57.6 63.2 0.021 57.5 61.2 0.004 57.4 66.9 <0.001 57.1 62.7 66.2 <0.001
 Ex-smoker, % 22.3 22.4 15.5 22.5 19.4 22.3 21.8 22.6 20.0 13.9
 Current smoker, % 18.7 18.7 21.4 18.7 19.4 19.0 11.4 18.9 17.3 20.0
Drinking status
 Non-drinker, % 50.3 50.3 51.8 0.293 50.3 51.2 <0.001 50.1 57.4 0.016 50.0 52.7 55.4 <0.001
 Ex-drinker, % 6.1 6.1 5.0 6.2 3.3 6.1 4.9 6.3 4.0 4.6
 Current drinker, % 42.2 42.2 43.2 42.0 45.6 42.4 37.7 42.1 43.4 40.0
Mental stress
 Very high to high, % 18.4 18.2 29.1 <0.001 17.9 26.4 <0.001 18.4 19.6 0.086 17.6 25.0 26.2 <0.001
 Moderate, % 53.1 53.1 54.6 53.1 54.0 53.0 56.1 52.9 55.3 49.2
 Low, % 27.1 27.3 16.4 27.6 19.7 27.2 24.2 27.9 19.8 24.6
Motivation
 Very high to high, % 69.4 69.4 69.1 0.159 69.2 71.2 0.006 69.4 66.9 0.058 69.3 70.8 60.0 0.001
 Moderate, % 27.2 27.2 27.7 27.2 27.6 27.1 31.3 27.1 27.6 36.9
 Low, % 2.0 1.9 3.2 2.0 1.2 2.0 1.8 2.0 1.6 3.1
Life events, % 10.3 10.1 17.7 <0.001 10.2 11.3 0.358 10.3 8.9 0.412 10.1 11.7 12.3 0.212
Underlying diseases, % 42.8 43.1 27.3 <0.001 43.2 36.4 0.001 42.6 50.3 0.005 43.3 39.1 33.9 0.012

Age and BMI showed mean values (standard deviations).

Analysis of variance was used for means and chi-square test was used for proportions.

Table 2 indicates crude, age- and sex-adjusted, and multivariable HRs and 95% CIs of incident HZ according to family histories for each first-degree relative and its combination, and the number of family histories of HZ. Compared to no history of each family member, a history of brother or sister was associated with the risk of incident HZ while histories of father and mother were not. The respective multivariable HRs (95%CIs) of incident HZ were 1.67 (1.04–2.69), 0.88 (0.39–2.00), and 1.17 (0.76–1.79). When comparing to no family histories of first-degree relatives, the multivariable HRs (95%CIs) were 1.34 (0.77–2.34) for a history of brother or sister alone, but 4.81 (1.78–13.00) for a history of mother plus brother or sister. The multivariable HRs were not calculated for histories of father plus mother, father plus brother or sister, and father plus mother plus brother or sister because of no or one case of HZ. As for the number of family histories, the multivariable HRs (95%CI) was 1.08 (0.76–1.54) for one relative (father, mother, or brother or sister) and 2.75 (1.13–6.70) for two or more relatives.

Table 2 Hazard ratios of incident herpes zoster according to family histories of HZ
Family history of HZ No of participants No of cases Total
person-
years
Incidence
(per 1000 person-years)
Crude
HR (95%CI)
Age- and sex-adjusted
HR (95%CI)a
Multivarible
HR (95%CI)b
Histories of any first-degree relatives
 No 9407 300 27627.1 10.9 1.00 1.00 1.00
 Yes 1123 41 3366.2 12.2 1.12 (0.81–1.56) 1.21 (0.87–1.69) 1.17 (0.84–1.63)
Number of histories of first-degree relatives
 0 9407 300 27627.1 10.9 1.00 1.00 1.00
 1 1058 36 3175.3 11.3 1.04 (0.73–1.46) 1.11 (0.78–1.57) 1.08 (0.76–1.54)
 ≥2 65 5 190.9 26.2 2.40 (0.99–5.81) 2.71 (1.12–6.58)* 2.75 (1.13–6.70)*
History of father
 No 10310 335 30327.2 11.0 1.00 1.00 1.00
 Yes 220 6 666.1 9.0 0.82 (0.36–1.83) 0.93 (0.41–2.10) 0.88 (0.39–2.00)
History of mother
 No 9885 318 29056.8 10.9 1.00 1.00 1.00
 Yes 645 23 1936.5 11.9 1.09 (0.71–1.66) 1.21 (0.79–1.86) 1.17 (0.76–1.79)
History of brother or sister
 No 10204 323 30032.5 10.8 1.00 1.00 1.00
 Yes 326 18 960.8 18.7 1.74 (1.08–2.80)* 1.67 (1.04–2.68)* 1.67 (1.04–2.69)*
Combination of histories of first-degree relatives
 None 9407 300 27627.1 10.9 1.00 1.00 1.00
 Father only 185 5 560.9 8.9 0.82 (0.34–2.00) 0.95 (0.39–2.31) 0.89 (0.37–2.17)
 Mother only 589 18 1773.4 10.1 0.94 (0.58–1.50) 1.04 (0.64–1.69) 1.00 (0.62–1.62)
 Brother or sister only 284 13 841.0 15.5 1.42 (0.82–2.48) 1.35 (0.77–2.35) 1.34 (0.77–2.34)
 Father plus mother 23 0 71.1 - - - -
 Father plus brother or sister 9 0 27.8 - - - -
 Mother plus brother or sister 30 4 85.7 46.7 4.30 (1.60–11.54)† 4.78 (1.78–12.84)† 4.81 (1.78–13.00)†
 Father plus mother plus brother or sister 3 1 6.3 158.3 14.61 (2.05–104.08)† 17.70 (2.48–126.51)† 16.79 (2.29–123.35)†

aAdjusted for age and sex.

bAdjusted further for BMI, smoking status, drinking status, mental stress, motivation, life events, and underlying diseases.

*P < 0.05, †P < 0.01

Discussion

In our community-based prospective cohort study of Japanese men and women aged ≥50 years living in Shozu County, a history of brother or sister was associated with a higher risk of incident HZ compared to no history of the siblings. When comparing to no family histories of the first-degree relatives, a history of mother plus brother or sister, and two or more number of family histories were associated with a higher risk of incident HZ.

A study for 504 cases and 523 controls of Americans matched by age, sex, and race reported that the ORs (95%CIs) of HZ were 4.50 (3.15–6.41) for a history of single blood relative and 13.77 (5.85–32.39) for that of multiple blood relatives, compared to no family history [4]. The following report of that study of 1103 cases and 523 controls showed the corresponding ORs (95%CIs) of 5.24 (3.79–7.23) and 17.15 (7.50–39.18), respectively [5]. A study for 389 cases and 511 controls of Americans matched by age, sex, immune compromise and vaccination statuses reported that the ORs (95%CIs) of HZ was 1.87 (1.34–2.60) for a history of the first-degree relatives compared to no family history [6]. A study for 217 cases and 200 controls of Iranians matched by age and sex showed that the OR (95%CI) of HZ were 4.91 (2.73–8.85) for a history of the first-degree relatives and 4.77 (2.16–10.54) for a history of the second-degree relatives compared to no each history [7]. A study for 656 cases and 656 controls of Americans matched by age, sex, and zoster vaccination reported OR (95%CI) of 1.17 (0.82–1.65) for a history of parents and 1.80 (1.16–2.79) for a history of siblings compared to no history of each relative [8]. A study for 250 cases and 500 controls of French matched by age and sex reported OR (95%CI) of 1.70 (0.96–3.01) for a history of father, 1.89 (1.24–2.88) for a history of mother, 2.87 (1.70–4.81) for a history of brother or sister compared to none of each history [9]. The stronger association for a history of brother or sister in the above two studies was consistent with our result. A Chinese population-based case-control study of 277 cases and 678 controls matched by age reported ORs (95%CI) of 2.4 (1.4–4.3) for a history of first-degree relatives compared to no family history [10]. To our best knowledge, this is the first to show significant associations of family histories and the number of family histories with the risk of incident HZ.

The strength of the present study included a fairly-high participation rate, systematic ascertainment of HZ cases, and the confirmation of HZ diagnosis by polymerase chain reaction detection of VZV [20]. However, our study had several limitations. First, the participants’ family histories of HZ were obtained from self-reports and were not validated by family records. A possible explanation for the lack of association between a history of father or mother and the risk of HZ may be its insufficient recall compared to a history of brother or sister due to the generational difference. Second, the number of incident HZ cases was small in the family history of HZ especially among the combination of histories of first-degree relatives to detect by sufficient statistical power. Finally, we cannot ignore the impact of residual confounding factors such as a history of varicella.

Conclusion

Family histories of mother plus brother or sister and two or more first-degree relatives were associated with a higher risk of incident HZ among the free-living Japanese population.

Abbreviations
CI

confidence interval

HR

hazard ratio

HZ

herpes zoster

SHEZ study

Shozu herpes zoster study

VZV

varicella-zoster virus

BMI

body mass index

OR

odds ratio

HR

hazard ratio

Declarations

Ethics approval and consent to participate

The analysis of data from the SHEZ study was conducted according to the Ethical Guidelines for Epidemiological Research and the Ethical Guidelines for Clinical Studies after obtaining written informed consent from all participants. This study was approved by the Ethics Committee of Osaka University Graduate School of Medicine (ethical approval number 18384), Research Foundation for Microbial of Osaka University, National Institute of Biomedical Innovation, and Nara Medical University School of Medicine.

Consent for publication

Not applicable.

Data availability statement

The data will not available to the others except for a academic scientists with investigator support after the approval of the study committee.

Competing interests

All authors have declared no conflicts of interest.

Funding

This work was funded by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labour and Welfare for Research on Publicly Essential Drugs and Medical Devices (fiscal year 2008–2010) [KHC1102] and for Public-private Sector Joint Research on Publicly Essential Drugs (fiscal year 2011–2012) [KHC1102], as well as research funds from the Research Foundation for Microbial Diseases of Osaka University.

Author’s contributions

Keiko Kinumaki analyzed the data and drafted the manuscript. Hiroyasu Iso, Hironori Imano, Yukiko Takao, Yoshinobu Okuno, Yasuko Mori, Hideo Asada, Koichi Yamanishi provided critical feedback for the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank the following medical organization for providing us this valuable research opportunity as well as information, samples, and feedback: Shozu County Medical Society, Shodoshima Federation of Self-Government Bodies. Tonosho town autonomous liaison council, Shodoshima town government, and Tonosho town government.

References
 
© The Author(s) 2022.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
http://creativecommons.org/licenses/by/4.0/
feedback
Top